[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349500-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-349500-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","multidimensional-molecular-mechanisms-of-drug-resistance-in-breast-cancer-implications-for-clinical-decision-making-and-treatment-strategies","Multidimensional molecular mechanisms of drug resistance in breast cancer - Implications for clinical decision‑making and treatment strategies","","Breast cancer has the highest incidence among malignant tumors in women worldwide. Despite progress from targeted therapy, chemotherapy, and endocrine therapy, acquired resistance continues to undermine prognosis. This review systematizes five core resistance mechanisms: drug efflux via ATP-binding cassette transporters; hypoxic immunosuppressive tumor microenvironment and breast cancer stem cells; epigenetic reprogramming through DNA methylation, histone modifications, and non-coding RNAs; compensatory DNA damage repair pathway activation; and metabolic reprogramming that fuels growth and promotes immune evasion. It also summarizes therapeutic strategies such as combined targeted therapy, immunotherapy, and novel drug delivery systems.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/multidimensional-molecular-mechanisms-of-drug-resistance-in-breast-cancer-implications-for-clinical-decision-making-and-treatment-strategies/349500/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/multidimensional-molecular-mechanisms-of-drug-resistance-in-breast-cancer-implications-for-clinical-decision-making-and-treatment-strategies/349500.png","ImageObject",300,407,{"name":42,"@type":43},"awa","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-14","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What are the key mechanisms of drug resistance covered in the review?","Question",{"text":63,"@type":64},"The review summarizes five core mechanisms: drug efflux transporter overexpression, tumor microenvironment-driven hypoxia and immunosuppression with breast cancer stem cells, epigenetic reprogramming, compensatory DNA damage repair activation, and metabolic reprogramming that supports tumor survival and proliferation.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does the tumor microenvironment contribute to treatment resistance?",{"text":68,"@type":64},"It describes a hypoxic and immunosuppressive tumor microenvironment that sustains stemness and impairs treatment response, including through involvement of breast cancer stem cells.",{"name":70,"@type":61,"acceptedAnswer":71},"What therapeutic strategies does the review suggest to address resistance?",{"text":72,"@type":64},"It highlights potential strategies including combined targeted therapy, immunotherapy, and novel drug delivery systems to overcome multidimensional therapy resistance and improve patient survival.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},349500,1790189076,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},3985747858093,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","ONCOLOGY REPORTS 56: 162, 2026  \nMultidimensional molecular mechanisms of drug resistance in breast cancer: Implications for clinical decision‑making and treatment strategies (Review)  \nWENYA XU 1 , SHIYAO KANG 1 , SHAOCHEN XIN 1 , YANBIN WU 1 , YUAN ZHAO2 and MIAOMIAO SHENG 1  \n1  \nLaboratory of Molecular Genetics of Aging and Tumor, Medical School, Kunming University of Science and Technology,  \n2  \nKunming, Yunnan 650500, P.R. China; Department of Thyroid and Breast Surgery, Kunming University of Science and Technology Affiliated Puer City People's Hospital, Puer, Yunnan 665000, P.R. China  \nReceived February 14, 2026; Accepted June 26, 2026  \nDOI: 10. 3892/or.2026.9167  \nAbstract. Breast cancer has the highest incidence among malignant tumors in women worldwide. Although targeted therapy, chemotherapy, and endocrine therapy have achieved significant efficacy, acquired resistance remains a major challenge affecting patient prognosis . The present review systematically outlines five core mechanisms of resistance to breast cancer treatment, including overexpression of ATP‑binding cassette transporters that reduce intracellular drug accumulation; a hypoxic and immunosuppressive tumor microenvironment, together with breast cancer stem cells, that sustains stemness and impairs treatment response; DNA methylation, histone modifications, and non‑coding RNAs that mediate epigenetic reprogramming, leading to silencing of tumor suppressors or activation of resistance pathways; compensatory activation of multiple DNA damage repair  \npathways, including homologous recombination, non‑homol‑ ogous end joining, base excision repair, nucleotide excision repair, and mismatch repair, which compromises the efficacy of chemotherapy and poly (ADP‑ribose) polymerase inhibi‑ tors; and metabolic reprogramming involving glycolysis, amino acid, nucleotide, and lipid metabolism that supplies tumor cells with energy, reducing equivalents, and biomass for proliferation, while simultaneously promoting immune evasion . Corresponding to these mechanisms, this review also summarizes potential therapeutic strategies, including combined targeted therapy, immunotherapy, and novel drug delivery systems. Therefore, a comprehensive dissection of the multidimensional networks mediating therapy resistance in breast cancer will provide both theoretical foundationsand practical pathways for discovering novel biomarkers,  \nCorrespondence to: Professor Miaomiao Sheng, Laboratory of Molecular Genetics of Aging and Tumor, Medical School, Kunming University of Science and Technology, Chenggong Campus, 727 South Jingming Road, Kunming, Yunnan 650500, P.R. China  \nE‑mail: [shengmm@kust.edu.cn](shengmm@kust.edu.cn)  \nDr Yuan Zhao, Department of Thyroid and Breast Surgery, Kunming University of Science and Technology Affiliated Puer City People's Hospital, 44 Zhenxing Avenue, Simao, Puer, Yunnan 665000, P.R. China  \nE‑mail: [9y323023@kust.edu.cn](9y323023@kust.edu.cn)  \nAbbreviations: TME, tumor microenvironment; BCSCs, breast cancer stem cells; DDR, DNA damage repair; HRR, homolo‑ gous recombination repair; NHEJ, non‑homologous end join‑ ing; BER, base excision repair; NER, nucleotide excision repair; MMR, mismatch repair; PARPi, poly(ADP‑ribose) polymerase inhibitors; HER2, human epidermal growth factor receptor 2; TNBC, triple‑negative breast cancer; HR, hormone receptor; ER, estrogen receptor; SERMs, selective estrogen receptor modula‑ tors; SERDs, selective estrogen receptor degraders; AIs, aroma‑ tase inhibitors; FDA, U.S. Food and Drug Administration; ESR1, estrogen receptor 1; PI3K, phosphatidylinositol 3‑kinase; AKT, protein;  \nICIs, immune checkpoint inhibitors; PD‑1, programmed cell death pro‑ tein 1; PD‑L1, programmed death ligand 1; VEGF, vascular endothelial growth factor; MDR, multidrug resistance; ABCB1, ATP‑binding cas‑ sette subfamily B member 1; ABCC1, ATP‑binding cassette subfamily C member 1; P‑gp, P‑glycoprotein; ABCG2, ATP‑binding cassette sub‑ family ","cbCainZFYXnlm7mV","https://ap.wps.com/l/cbCainZFYXnlm7mV","pdf",4323909,14,"English","# Contents\n## 1. Introduction\n## 2. Molecular subtypes of breast cancer and targeted therapies\n## 3. Aberrant expression of drug efflux proteins\n## 4. Tumor microenvironment reprogramming\n## 5. Dysregulation of epigenetics\n## 6. Enhanced DNA damage repair mechanisms\n## 7. Alterations in metabolic reprogramming\n## 8. Conclusions and future perspectives","[{\"question\":\"What are the key mechanisms of drug resistance covered in the review?\",\"answer\":\"The review summarizes five core mechanisms: drug efflux transporter overexpression, tumor microenvironment-driven hypoxia and immunosuppression with breast cancer stem cells, epigenetic reprogramming, compensatory DNA damage repair activation, and metabolic reprogramming that supports tumor survival and proliferation.\"},{\"question\":\"How does the tumor microenvironment contribute to treatment resistance?\",\"answer\":\"It describes a hypoxic and immunosuppressive tumor microenvironment that sustains stemness and impairs treatment response, including through involvement of breast cancer stem cells.\"},{\"question\":\"What therapeutic strategies does the review suggest to address resistance?\",\"answer\":\"It highlights potential strategies including combined targeted therapy, immunotherapy, and novel drug delivery systems to overcome multidimensional therapy resistance and improve patient survival.\"}]","Multidimensional molecular mechanisms of drug resistance in breast cancer - Implications for clinical decision‑making and treatment strategies | PDF",1790083896,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dbfa6e6eb12756d9acfff46e3305cf1b.webp",983,1357,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f286a8809adef5628f9bb9ba9ff711bb.webp",982,1356,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/12ce35ea6bd974aeee2006f2fb3ea275.webp",981,1354,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/82c9cc847a0ee3fba99bcaa22ddd0c8c.webp",980,1353]